EVALUATION OF COVID-19 VACCINES IN PRIMARY PREVENTION AGAINST INFECTIONS AND REDUCTION IN SEVERITY OF ILLNESS FOLLOWING THE OUTBREAK OF SARS-COV-2 OMICRON VARIANT IN SHANGHAI

被引：0
|
作者：
Yang, D. [1 ]
Weng, H. [2 ]
Song, Y. [1 ]
Li, J. [3 ]
Lu, X. [3 ]
Yang, W. [2 ]
Chen, Z. [4 ]
Xuan, J. [3 ]
Bai, C. [1 ]
Wang, Y. [5 ]
机构：
[1] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China
[2] Suvalue Healthcare Sci Co Ltd, Shanghai, Peoples R China
[3] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[4] Guangzhou Med Univ, Dept Clin Res Management Off, Affiliated Hosp 3, Guangzhou, Peoples R China
[5] Army Med Univ, Inst Surg Res, Daping Hosp,Wound Trauma Med Ctr, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH100
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [1] Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai
    Yang, Dawei
    Weng, Huifen
    Wang, Rui
    Li, You
    Zhang, Hao
    Shao, Shifeng
    Huang, Hunan
    Song, Yuanlin
    Chen, Xiaoyan
    Hou, Dongni
    Wu, Yin
    Lu, Xingwei
    Yang, Wei
    Chen, Zhengguo
    Hu, Xiaohan
    Xuan, Jianwei
    Bai, Chunxue
    Wang, Yaoli
    FRONTIERS IN MEDICINE, 2023, 10
  • [2] Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    Henry, Brandon M.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1799 - 1802
  • [3] Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
    Araf, Yusha
    Akter, Fariya
    Tang, Yan-dong
    Fatemi, Rabeya
    Parvez, Md Sorwer Alam
    Zheng, Chunfu
    Hossain, Md Golzar
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1825 - 1832
  • [4] Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
    Chen, Zhonghao
    Zhang, Ying
    Wang, Meng
    Islam, Md Sahidul
    Liao, Ping
    Hu, Yuanjia
    Chen, Xin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4629 - 4641
  • [5] Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
    Chen, Zhonghao
    Zhang, Ying
    Wang, Meng
    Islam, Md Sahidul
    Liao, Ping
    Hu, Yuanjia
    Chen, Xin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4629 - 4641
  • [6] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [7] Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
    Abas, Abdul Hawil
    Marfuah, Siti
    Idroes, Rinaldi
    Kusumawaty, Diah
    Fatimawali
    Park, Moon Nyeo
    Siyadatpanah, Abolghasem
    Alhumaydhi, Fahad A.
    Mahmud, Shafi
    Tallei, Trina Ekawati
    Bin Emran, Talha
    Kim, Bonglee
    MOLECULES, 2022, 27 (07):
  • [8] Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
    Du, Yuxuan
    Chen, Long
    Shi, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [9] Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022
    Li, Juan
    Song, Rui
    Yuan, Zheng
    Xu, Zheng
    Suo, Luodan
    Wang, Qing
    Li, Yuan
    Gao, Yanlin
    Li, Xiaomei
    Chen, Xiaoyou
    Wu, Jiang
    VACCINES, 2022, 10 (08)
  • [10] COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
    Zeng, Cong
    Evans, John P.
    Chakravarthy, Karthik
    Qu, Panke
    Reisinger, Sarah
    Song, No-Joon
    Rubinstein, Mark P.
    Shields, Peter G.
    Li, Zihai
    Liu, Shan-Lu
    CANCER CELL, 2022, 40 (02) : 117 - 119
12345